HEAD AND NECK (HNSCC)
Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Cancer's 'Extra DNA' in desperate patients
Disease control OngoingThis early-phase study tests an experimental oral drug, BBI-355, in people with advanced solid tumors (like certain breast, ovarian, lung, and other cancers) that have extra copies of cancer-driving genes. The goal is to find a safe dose and see if BBI-355, alone or with other ta…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 11:14 UTC
-
Gene therapy patients monitored for years in new safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 400 adults who previously received A2Bio gene therapy for various solid tumors, including lung, colon, and pancreatic cancers. The main goal is to track long-term safety and see how well the treatment effects last over time. Participants do not receive ne…
Matched conditions: HEAD AND NECK (HNSCC)
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:23 UTC